Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chi Sheng Pharma & Biotech CoROCO:4111 -0.33%84 Days Inventory is 44.79 as of Dec. 2025, which is 2% above its 10-year median of 44.04. GuruFocus rates ROCO:4111 with a GF Score™ of 84/100 and a GF Value™ of NT$33.16 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 786 Medical Devices & Instruments companies, Chi Sheng Pharma & Biotech Co ranks better than 94.91% on this metric.
The historical rank and industry rank for Chi Sheng Pharma & Biotech Co's Days Inventory or its related term are showing as below:
ROCO:4111'
s Days Inventory Range Over the Past 10 Years
Min: 37.63 Med: 44.04 Max: 48.15
Current: 43.94
During the past 13 years, Chi Sheng Pharma & Biotech Co's highest Days Inventory was 48.15. The lowest was 37.63. And the median was 44.04.
ROCO:4111's Days Inventory is ranked better than 94.91% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs ROCO:4111: 43.94
Inventory Turnover measures how fast the company turns over its inventory within a year.
Chi Sheng Pharma & Biotech Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 2.04.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Chi Sheng Pharma & Biotech Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.29.
Chi Sheng Pharma & Biotech Co (ROCO:4111) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Chi Sheng Pharma & Biotech Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Chi Sheng Pharma & Biotech Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Chi Sheng Pharma & Biotech Co Days Inventory Related Terms
Chi Sheng Pharma & Biotech Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chi Sheng Pharma & Biotech Co Days Inventory Chart
ROCO:4111 vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Chi Sheng Pharma & Biotech Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chi Sheng Pharma & Biotech Co Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chi Sheng Pharma & Biotech Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Chi Sheng Pharma & Biotech Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chi Sheng Pharma & Biotech Co (ROCO:4111) has a Days Inventory of 44.79 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Chi Sheng Pharma & Biotech Co and its competitors. This is near median its historical median of 44.04. Over the past decade, Chi Sheng Pharma & Biotech Co's Days Inventory has ranged from 37.63 to 48.15. According to the industry distribution chart, Chi Sheng Pharma & Biotech Co ranks #40 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 5.1%.
Is Chi Sheng Pharma & Biotech Co's Days Inventory too high?
Chi Sheng Pharma & Biotech Co's current Days Inventory of 44.79 is near median its 10-year median of 44.04. Over the past 10 years, this metric has ranged from a low of 37.63 to a high of 48.15. The Medical Devices & Instruments industry median Days Inventory is 179.60. Chi Sheng Pharma & Biotech Co's value of 44.79 is 75.1% below this industry median. Based on the distribution chart, Chi Sheng Pharma & Biotech Co ranks #40 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Chi Sheng Pharma & Biotech Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chi Sheng Pharma & Biotech Co's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Chi Sheng Pharma & Biotech Co ranks #40 out of 786 companies for Days Inventory. This places Chi Sheng Pharma & Biotech Co in the top 5% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. Chi Sheng Pharma & Biotech Co's value of 44.79 is 75.1% below this benchmark. Historically, Chi Sheng Pharma & Biotech Co's own Days Inventory has ranged from 37.63 to 48.15 over the past decade. While the company's 10-year median is 44.04 vs. the industry median of 179.60, Chi Sheng Pharma & Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chi Sheng Pharma & Biotech Co's current Days Inventory of 44.79 is 75.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Chi Sheng Pharma & Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chi Sheng Pharma & Biotech Co's current Days Inventory is 44.79, which is near median its own 10-year median of 44.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chi Sheng Pharma & Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Chi Sheng Pharma & Biotech Co (ROCO:4111) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$33.16, compared to a current price of NT$29.95 — trading 9.7% below its estimated fair value. The current Days Inventory is 44.79, which is near median its 10-year median of 44.04 and 75.1% below the Medical Devices & Instruments industry median of 179.60. Chi Sheng Pharma & Biotech Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Chi Sheng Pharma & Biotech Co (ROCO:4111), the current Days Inventory is 44.79 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chi Sheng Pharma & Biotech Co (ROCO:4111) Overvalued in 2026?
Based on GuruFocus' analysis, Chi Sheng Pharma & Biotech Co stock appears to be undervalued.
The current stock price of NT$29.95 is trading 9.7% below its estimated GF Value™ of NT$33.16.
GuruFocus considers Chi Sheng Pharma & Biotech Co to be Modestly Undervalued.
Key valuation signals for ROCO:4111:
Days Inventory: 44.79 (near median its 10-year median of 44.04)
GF Value™: NT$33.16 vs. price of NT$29.95 (9.7% below fair value)
Industry Position: 75.1% below the Medical Devices & Instruments median (#40 of 786)
No single metric tells the full story. See the ROCO:4111 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chi Sheng Pharma & Biotech Co Business Description
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.
84GF Score
Get the complete analysis for ROCO:4111
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4111 has been successfully added to your 
